Browsing by Author Horvath, Lisa

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 52  next >
Issue DateTitleAuthor(s)Citation
2006Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis.Horvath, Lisa; Kench, James; Lee, Cheok; Biankin, Andrew V.; Breit, Samuel N; Brenner, Phillip C.; Brown, David A.; Delprado, Warick; Gardiner-Garden, Margaret; Golovsky, David; Grygiel, John J.; Henshall, Susan M.; Kooner, Raji; O'Neill, Gordon F.A.; Rasiah, Krishan K.; Stricker, Phillip D.; Sutherland, Robert L.; Turner, Jennifer Jane; Central Clinical School: Medicine; School of Medical Sciences: Pathology; Central Clinical School: MedicineAberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis., Cancer Epidemiology Biomarkers & Prevention 2005, vol.15,(4),2006,pp 711-716
2017Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancerHorvath, Lisa; Kench, James; Lee, Kenneth; Armstrong, Nicola J; Buske, Fabian Andreas; Colino-Sanguino, Yolanda; et, al; Gould, Cathryn M.; Nair, S; Qu, Wenjia; Song, Jenny; Statham, Aaron; Taylor, Kylie M.; Vald├ęs-Mora, Fatima; Central Clinical School: Medicine; Central Clinical School: Pathology; Concord Clinical School: MedicineAcetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer, Nature Communications, vol.8, 1, 2017,pp N/A-N/A
2014Adjuvant chemotherapy in elderly patients with pancreatic cancerGill, Anthony; Kench, James; Australian Pancreatic Cancer Genome Initiative, A; Biankin, Andrew V.; Chang, David K.; Chantrill, Lorraine; Chin, Venessa; Chou, Angela; Colvin, Emily; Horvath, Lisa; Humphris, Jeremy; Johns, Amber; Nagrial, Adnan; Nguyen, Nam Q; Pajic, Marina; Pinese, Mark; Samra, JS; Scarlett, Christopher; Sutherland, Robert L.; Deans Unit: (CIPHER); School of Medical Sciences: PathologyAdjuvant chemotherapy in elderly patients with pancreatic cancer, British Journal of Cancer, vol.110, 2, 2014,pp 313-319
2010Cetuximab is Associated with Excessive Toxicity when Combined with Bevacizumab Plus mFOLFOX6 in Metastatic Colorectal CarcinomaChen, Helen X.; Hamilton, Anne; Horvath, Lisa; Christos, Paul; Kindler, Hedy L.; Matulich, Daniel; Ocean, Allyson; Polite, Blase; Sparano, Joseph A; Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineCetuximab is Associated with Excessive Toxicity when Combined with Bevacizumab Plus mFOLFOX6 in Metastatic Colorectal Carcinoma, Clinical Colorectal Cancer, vol.9, 5,pp 290-296
2014Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancerBoyer, Michael; Gurney, Howard; Horvath, Lisa; Mahon, Kate; Marx, Gavin; Pavlakis, Nick; Stockler, Martin; Castillo, Lesley; Chiam, K; Clark, Susan J.; Daly, R; Lee, B Y; Lin, H-M; Mallesara, G; Nguyen, Q; Swarbrick, A.; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; School of Public Health: Public Health; Medicine; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreCirculating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer, British Journal of Cancer, vol.110, 10, 2014,pp 2462-2471
2016CMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responsesBradstock, Kenneth; Bryant, Christian; Clark, Georgina; Fromm, Phillip; Hart, Derek; Ho Lo, Tsun; Horvath, Lisa; Joshua, Douglas; Papadimitrious, Michael Stephen; Silveira, Pablo; Van Kooten Losio, Nicolas; Verma, Nirupama; Anguille, Sebastien; Barnard, Ross; et al, Various; Hsu, Jennifer; Mahler, Stephen; Munster, David; Nagasakid, Tomoko; Prue, R; Turtle, Cameron; Vukovic, Peter; Western Clinical School: Westmead Institute for Medical Res; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteCMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses, OncoImmunology, vol.5, 6, 2016,pp 1-12
2015Cytokine profiling of docetaxel-resistant castration-resistant prostate cancerBoyer, Michael; Horvath, Lisa; Mahon, Kate; Marx, Gavin; Pavlakis, Nick; Stockler, Martin; Breit, Samuel; Brown, David; Castillo, Lesley; Chatfield, Mark; Chiam, K; Daly, R; Henshall, Susan; Lee, B Y; Lee-Ng, K K Michelle; Lin, H-M; Molloy, Mark; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Public Health: Public Health; Medicine; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreCytokine profiling of docetaxel-resistant castration-resistant prostate cancer, British Journal of Cancer, vol.112, 8, 2015,pp 1340-1348
2017Discovering cancer vulnerabilities using high-throughput micro-RNA screeningHorvath, Lisa; Dodson, Eoin; Elsworth, Benjamin; Gould, Cathryn M.; Marshall, Glenn; Mestdagh, Pieter; Nikolic, Iva; Simpson, Kaylene; Swarbrick, Alexander; Wu, Sunny Z.; Central Clinical School: MedicineDiscovering cancer vulnerabilities using high-throughput micro-RNA screening, Nucleic Acids Research, vol.45, 22, 2017,pp 12657-12670
2017A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancerGurney, Howard; Horvath, Lisa; Hoy, Andrew; Marx, Gavin; Stockler, Martin; Briscoe, Karen; Daly, Roger; Lin, Hui-Ming; Mahon, Kate; Mallesara, Girish; Meikle, Peter; Mundra, Piyushkumar; Parton, Robert G.; Spielman, Calan; Weir, Jacquelyn; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; School of Medical Sciences: Physiology; SAHCS: Medicine; NH&MRC Clinical Trials CentreA distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer, International Journal of Cancer, vol.141, 10, 2017,pp 2112-2120
2008DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinomaHorvath, Lisa; Lee, Cheok; McCaughan, Brian; Chan, Charles; Cooper, Wendy A.; Currey, N; Kennedy, Catherine; Kohonen-Corish, Maija R.J.; Seng, TJ; Sutherland, Robert L.; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: SurgeryDLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma, British Journal of Cancer, vol.99, 2, 2008,pp 375-382
2013EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinomaGill, Anthony; Horvath, Lisa; McCaughan, Brian; O'Toole, Sandra; Trent, Ronald; Yip, Po Yee; Yu, Bing; Clarkson, A; Cooper, Wendy; Farzin, M; Kench, James; Kohonen-Corish, Maija R.J.; Lum, Trina; Mercorella, B; Ng, Chiu Chin; Deans Unit: (CIPHER); Central Clinical School: Medicine; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: Medicine; Medicine; Central Clinical School: MedicineEGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma, Journal of Clinical Pathology (JCP Online), vol.66, 9, 2013,pp 744-748
2009Elevated level of inhibin-alpha subunit is pro-tumourigenic and pro-metastatic and associated with extracapsular spread in advanced prostate cancer.Horvath, Lisa; Achen, M; Balanathan, P; Pedersen, John; Risbridger, Gail Petuna; Stacker, S; Wang, H; Williams, Elizabeth D.; Central Clinical School: MedicineElevated level of inhibin-alpha subunit is pro-tumourigenic and pro-metastatic and associated with extracapsular spread in advanced prostate cancer., British Journal of Cancer, vol.100, 11,pp 1784-1793
2011Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer BiomarkersHorvath, Lisa; Kench, James; Coolen, Marcel; Devaney, James; et al, various; Henshall, Susan M.; Hulf, Toby; Patterson, K I; Qu, Wenjia; Song, Jenny; Statham, Aaron; Stirzaker, Clare; Tabor, Bruce; Central Clinical School: Medicine; School of Medical Sciences: PathologyEpigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers, Cancer Epidemiology, Biomarkers and Prevention, vol.20, 1, 2011,pp 148-159
2013Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancerHorvath, Lisa; Armstrong, N; Clark, S; Hulf, Toby; Kench, J; Nair, S; Patterson, K; Qu, W; Sibbritt, T; Song, J; Stirzaker, C; Sutherland, R; Wiklund, E; Central Clinical School: MedicineEpigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer, Oncogene, vol.32, 23, 2013,pp 2891-2899
2014ERG induces taxane resistance in castration-resistant prostate cancerHorvath, Lisa; Kench, James; Beltran, Himisha; Chae, Sung Suk; Cheung, Cynthia; et al, Various; Fontugne, Jacqueline; Galletti, Giuseppe; MacDonald, Theresa; Matov, Alexandre; Mosquera, Juan; OToole, Sandra; Sung, Matthew; Central Clinical School: Medicine; School of Medical Sciences: PathologyERG induces taxane resistance in castration-resistant prostate cancer, Nature Communications, vol.5, N/A, 2014,pp 1-12
2017The evolution of chemotherapy for the treatment of prostate cancerHorvath, Lisa; Eastham, James A.; Goldkorn, A.; Quinn, D. I.; Sandler, H. M.; Central Clinical School: MedicineThe evolution of chemotherapy for the treatment of prostate cancer, Annals of Oncology, vol.28, 11, 2017,pp 2658-2669
2014Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific deathHorvath, Lisa; Kench, James; Veillard, Anne-Sophie; Birch, S E; Chan, A-L; Chan, Peter; Chiam, K; Fox, Stephen B.; Haupt, S; Haupt, Y; Stricker, Phillip; Takano, E; Central Clinical School: Medicine; School of Medical Sciences: Pathology; School of Public Health: NH&MRC Clinical Trials CentreExpression of E6AP and PML predicts for prostate cancer progression and cancer-specific death, Annals of Oncology, vol.25, 12, 2014,pp 2392-2397
2014Expression of phosphorylated-mTOR during the development of prostate cancerHorvath, Lisa; Kench, James; Sutherland, Sarah; Henshall, Susan; Pe Benito, Ruth; Central Clinical School: Medicine; School of Medical Sciences: Pathology; Central Clinical School: MedicineExpression of phosphorylated-mTOR during the development of prostate cancer, The Prostate, vol.74, 12, 2014,pp 1231-1239
2015Extraprostatic Extension (EPE) of Prostatic Carcinoma: Is its Proximity to Surgical margin or Gleason Score Important?Gupta, Ruta; Horvath, Lisa; Kench, James; O'Connell, Rachel; Barrett, Wade; Delprado, Warwick; Haynes, Anne Marie; Stricker, Phillip D; Turner, Jennifer Jane; School of Medical Sciences: Pathology; Central Clinical School: Medicine; School of Medical Sciences: Pathology; NH&MRC Clinical Trials CentreExtraprostatic Extension (EPE) of Prostatic Carcinoma: Is its Proximity to Surgical margin or Gleason Score Important?, BJU International, vol.116, 3, 2015,pp 343-350
2015FAK Signaling in Human Cancer as a Target for TherapeuticsHorvath, Lisa; Daly, Roger J.; Lee, Brian; Timpson, Paul; Central Clinical School: MedicineFAK Signaling in Human Cancer as a Target for Therapeutics, Pharmacology & Therapeutics, vol.146, N/A, 2015,pp 132-149